Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by ontheDLon Jan 16, 2012 11:02am
543 Views
Post# 19407567

Golden Predator makes gains in the Yukon

Golden Predator makes gains in the Yukon

Golden Predator believes that surface geochemistry, magnetics and IP "all support the existence of a potential target well in excess of 1 km in strike length." The company also says it has all the required permits, including the Class 3 mining land use permit that is a requirement for additional exploration. It is authorized under a Type A water license, which expires in Dec. 2021. It also has a production license until Dec. 2021, and the 93 mining leases spanning the mine facilities, pits, waste dumps and adjacent drill indicated deposits, have expiry dates starting in 2016.

 

Golden Predator makes gains in the Yukon
The Northern Miner
The New Year got off to a strong start for Golden Predator (GPD-T) in the Yukon with drill results from the Sleeman zone at its flagship Brewery Creek ...

Bullboard Posts